Sunday, 15 Nov 2026 Breaking: US envoy Kushner says focus now on "facilitating direct engagement" between Russia, Europe on Ukraine peace talks
BREAKING: Apple launches AI platform | Tesla earnings beat estimates | Nvidia stock surges | Bitcoin crosses major resistance
Business

Retort Pharmaceuticals Refreshes Hercoff for a New Chapter in Accessible Throat Care

Retort Pharmaceuticals Refreshes Hercoff for a New Chapter in Accessible Throat Care

PRNewswire
Chennai (Tamil Nadu) [India], November 6: How a healthcare product reaches consumers can be as important as how it is formulated. For Retort Pharmaceuticals Pvt. Ltd., this thinking is shaping the next phase of Hercoff, its throat-care brand, as the company refreshes its market positioning and works to expand its availability through retail channels.
https://mmx.prnewswire.com/media/MS2028913/Retort-Founder-video-with-logo-1.mp4?id=OA3062562
With a single-dose sachet format alongside a conventional syrup bottle, Hercoff brings together two practical considerations in everyday product access: convenience and affordability. The renewed brand push reflects Retort Pharmaceuticals' ambition to develop Hercoff into a recognised household name in throat care.
Reimagining the everyday product experience
Hercoff is available in a 10 ml single-dose sachet and a 100 ml syrup bottle. The sachet format offers an alternative to a conventional bottle, with a defined serving size and a compact presentation designed for convenience.
The company has also developed retail packaging that allows boxes of sachets to function as counter dispensers, offering chemists and general stores a practical way to display the product.
These decisions reflect the brand's focus on the everyday retail experience, from how a product is presented at the counter to how consumers can purchase it in a convenient format.
Hercoff's formulation includes ingredients such as vasaka, mulethi, ginger, pippali and pudina. Its product positioning draws on these familiar ingredients while placing emphasis on accessibility and convenience.
From product availability to a wider market presence
Retort Pharmaceuticals is building its distribution network in Tamil Nadu while exploring opportunities to extend Hercoff's reach into the North-East.
The company's current efforts include outreach to distributors in Assam, Meghalaya, Tripura and Manipur, with markets such as Guwahati, Dibrugarh, Jorhat, Nagaon, Shillong, Agartala and Imphal among those identified for distribution development.
The objective is to build a wider retail presence through chemists and general stores, creating a foundation for the brand's longer-term growth.
Rather than treating the current market push as a one-time launch, the company sees distribution development as part of the broader process of establishing Hercoff in the throat-care category.
Building towards a household brand
For Retort Pharmaceuticals, the ambition for Hercoff extends beyond introducing a product or refreshing its packaging. The company wants to build a recognisable household throat-care brand, supported by convenient formats, an accessible price point and growing retail availability.
As it develops the brand's market presence, the next phase will focus on strengthening distribution and building familiarity with Hercoff among consumers and retail partners.
About Retort Pharmaceuticals Pvt. Ltd.
Retort Pharmaceuticals Pvt. Ltd., based in Chennai, is part of the Retort Group, a healthcare business with interests in Ayurvedic and allopathic products. The group describes its approach as bringing together Ayurvedic knowledge and modern medicine, with an emphasis on accessible healthcare.
For more information, visit the Retort Group website: https://retort.in/ / Email: admin@retort.in
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire. ANI will not be responsible in any way for the content of the same.)

Tags

Related News

Nvidia risks losing critical supply chain deals without Jensen Huang, warns Elon Musk
Business
Nvidia risks losing critical supply chain deals without Jensen Huang, warns Elon Musk

<p>New Delhi [India], November 14 (ANI): Tesla and SpaceX CEO Elon Musk has warned that Nvidia could lose some of its cr...

CCI approves Advent International-backed firm's stake acquisition in Yatharth Hospitals
Business
CCI approves Advent International-backed firm's stake acquisition in Yatharth Hospitals

<p>New Delhi [India], November 14 (ANI): The Competition Commission of India (CCI) on Saturday approved the acquisition...

India must develop its own semiconductor manufacturing machines, precision components: Ashwini Vaishnaw
Business
India must develop its own semiconductor manufacturing machines, precision components: Ashwini Vaishnaw

<p>New Delhi [India], November 14 (ANI): Union Minister for Electronics and Information Technology Ashwini Vaishnaw on S...

Battery PLI scheme achieves just 1.4 GWh capacity against 50 GWh target, faces delays: NITI Aayog report
Business
Battery PLI scheme achieves just 1.4 GWh capacity against 50 GWh target, faces delays: NITI Aayog report

<p>New Delhi [India], November 14 (ANI): India's Production Linked Incentive (PLI) scheme for Advanced Chemistry Cell (A...

Merck Foundation CEO: Transforming Diabetes Care, One Blue Point at a Time
Business
Merck Foundation CEO: Transforming Diabetes Care, One Blue Point at a Time

<p>BusinessWire India<br/>Accra [Ghana]/ Mumbai (Maharashtra) [India], November 14: On World Diabetes Day 2026, Senator...

‘Parampara’: Timeless Wisdom of the Vedas and India’s Living Traditions. Book by Pavan Kaushik
Business
‘Parampara’: Timeless Wisdom of the Vedas and India’s Living Traditions. Book by Pavan Kaushik

<p>VMPL<br/>New Delhi [India], November 14: Why do we tie a thread around our wrist? What is the significance of applyin...